All Episodes
Cannabinoid and Psychedelic Pharmacology and Drug Development — 251 episodes
Introduction to Notebook LM, AI, and Podcast Effectiveness in Education
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Receptor Pharmacology Cocktail Party Knowlege
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Expert Quiz Show
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Non-Expert Quiz Show
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 90 The Grand Finale Integrating All Pathways
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 89 Next-Gen Tools & Techniques (Cryo-EM, CRISPR, etc.)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 88 Pharmacogenomics & Precision Receptor Pharmacology
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 87 Biased Agonism & Allosteric Modulation
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 86 Orphan & Deorphanized Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 85 Multi-Hormonal Integration & Endocrine Networks
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 84 Incretin Receptors (GLP-1, GIP)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 83 Mineralocorticoid & Glucocorticoid Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 82 Growth Hormone & Prolactin Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 81 Peptide Hormone Receptors (e.g., ADH, Oxytocin)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 80 Adaptive Immunity in Therapy & Vaccines
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 79 Antigen Presentation & Dendritic Cell Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 78 Co-Stimulatory & Co-Inhibitory Receptors (CD28, CTLA-4, PD-1)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 77 T-Cell Receptors (TCR) & MHC Interaction
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 76 B-Cell Receptors (BCR)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 75 Opioid & Cannabinoid Receptors Revisited
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 74 Cholinergic Receptors (Muscarinic & Nicotinic)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 73 GABA & Glutamate as Neurotransmitter Systems
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 72 Serotonin (5-HT) Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 71 Dopamine Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 70 Mechanoreceptors & Specialized Senses
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 69 Photoreceptors (Vision)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 68 Olfactory Receptors (Smell)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 67 Taste Receptors (Gustation)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 66 Overview of Sensory Receptor Types
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 65 Anti-Adhesion Therapies & Tissue Engineering
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 64 Selectins & Immune Cell Trafficking
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 63 Cadherins & Cell-Cell Adhesion
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 62 Integrin Signaling Cascades (FAK, Src)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 61 Integrin Structure & ECM Binding
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 60 Clinical Exploitation of Developmental Pathways
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 59 Cross-Regulation Among Notch, Hedgehog, Wnt
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 58 Wnt/β-Catenin Pathway
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 57 Hedgehog Signaling
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 56 Notch Signaling Basics
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 55 TLR Therapeutic Outlook
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 53 TLRs in Disease & Autoimmunity
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 52 TLR Signaling Pathways (MyD88-Dependent & TRIF)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 51 TLR Structure & Classification
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 50 Orphan Nuclear Receptors & Drug Discovery
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 49 Retinoid & Vitamin D Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 48 Thyroid Hormone Receptor & Metabolic Control
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 47 Steroid Hormone Receptors (Estrogen, Androgen, etc.)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 46 Nuclear Receptor Fundamentals
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 45 TNF & Other Cytokine Receptor Superfamilies
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 44 Interferon Receptors & Antiviral Defenses
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 43 Interleukin Receptors & Immune Modulation
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 42 JAK-STAT Pathway in Cytokine Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 41 Cytokine Receptor Families & Signaling Overview
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 40 Therapeutic Targeting of Ser/Thr Kinase Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 39 SMAD-Independent Ser/Thr Kinase Pathways
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 38 BMP Receptors in Development & Regeneration
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 37 TGF-beta Receptor Signaling Mechanics
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 36 TGF-beta Superfamily Overview
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 35 RTK Therapeutics & Future Directions
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 34 RTK Dysregulation & Oncogenesis
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 33 JAK-STAT Crosstalk with RTKs
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 32 PI3K-AKT-mTOR Axis in RTK Signaling
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 31 RTK Signal Integration (RAS/RAF/MEK/ERK)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 30 FGFR Family
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 29 Insulin & IGF Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 28 PDGF & VEGF Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 27 EGF Receptor Family (ErbB)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 26 RTK Overview & Mechanisms
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 25 Ion Channelopathies & Therapeutic Interventions
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 24 TRP Channels Polymodal Sensor Proteins
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 23 Ionotropic Glutamate Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 22 GABAA_A & Glycine Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 21 Nicotinic Acetylcholine Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 20 Ligand-Gated Ion Channels (LGICs) The Basics
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 19 Voltage-Gated Calcium Channels
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 18 Voltage-Gated Potassium Channels
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 17 Voltage-Gated Sodium Channels
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 16 Ion Channel Fundamentals
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 15 GPCR Pharmacology Roundup
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 14 GPCR Mutations & Disease
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 13 GPCR Class C Metabotropic Glutamate & GABA_B Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 12 GPCR Class B Secretin-Like Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 11 GPCR Class A Rhodopsin-Like Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 10 GPCR Diversity Beta-Arrestins & Biased Signaling
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 9 GPCR Second Messengers II (Phosphoinositide Pathway)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 8 GPCR Second Messengers I (cAMP Pathway)
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 7 GPCR Activation & G-Protein Coupling
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 6 GPCR Architecture & Classification
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 5 Receptor Regulation Desensitization & Upregulation
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 4 Dose-Response Relationships & Pharmacodynamics
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 3 Receptor Binding Kinetics & Affinity
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 2 Key Terms & Concepts in Signal Transduction
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 1 The Universe of Human Receptors
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 54 TLR Agonists & Vaccine Development
90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 32 PI3K-AKT-mTOR Axis in RTK Signaling
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Expert Quiz Show Podcast
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Non-Expert Quiz Show Podcast
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 30 Conclusions and Spiral Recap
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 29 Future Developments and Controversies
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 28 Putting It All Together – Case Study
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 27 Applying Six Sigma and Other Continuous Improvement Tools
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 26 Advanced Topics in Process Chemistry and Scalability
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 25 Global Perspectives and Harmonization
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 24 Intellectual Property, Patents, and Regulatory Exclusivities
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 23 Pharmacovigilance and Post-Marketing Surveillance
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 22 Clinical Trial Design Nuances for Cannabinoid Therapies
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 21 Clinical Trial Design Nuances for Psychedelic Therapies
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 20 Safety Considerations Beyond the Lab (Societal and Ethical Implications)
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 19 Product Lifecycle Management and Post-Approval Changes
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 18 Process Analytical Technology (PAT) in Natural Products
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 17 Critical Material Attributes (CMAs) in Cannabis and Psychedelic Manufacturi
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 16 Label Accuracy in Psychedelic Products
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 15 Label Accuracy in Cannabinoid Products
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 14 Botanical Drug Development Guidance (FDA)
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 13 cGMP Fundamentals and Their Societal Impact
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 12 Phase-Appropriate Validation vs. Verification
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 11 Nitrosamine Impurities and Genotoxic Concerns
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 10 Control of Impurities (Organic, Inorganic, Residual Solvents) SUPPLEMENT
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 10 Control of Impurities (Organic, Inorganic, Residual Solvents)
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 9 Stability Testing and Shelf-Life Determination
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 8 Risk Management (ICH Q9) and Subjective Risk Assessments
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 7 Design of Experiments (D.O.E.) in Process Optimization
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 6 Analytical Method Development and Validation
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 5 Identifying CQAs and CPPs
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 4 Quality by Design (QbD) – Fundamentals SUPPLEMENT
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 4 Quality by Design (QbD) – Fundamentals
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 3 Phase-Appropriate Drug Development
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 2 Introduction to ICH Guidelines
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 1 FDA Drug Development Overview
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 0 Introduction
30 Day Psychedelic Pharmacology Podcast - SPECIAL TOPIC Lykos' Modomafetamine Rejection
30 Day Psychedelic Pharmacology Podcast - BONUS Spotlight on Sasha and Ann Shulgin and The Alexander Shulgin Foundation and Research Institute
30 Day Psychedelic Pharmacology Podcast - Expert Level Psychedelic Pharmacology Quiz Podcast
30 Day Psychedelic Pharmacology Podcast - Non-Expert Psychedelic Pharmacology Quiz Show Podcast
30 Day Psychedelic Pharmacology Podcast - Day 30 Closing Reflections
30 Day Psychedelic Pharmacology Podcast - Day 29 Future Directions
30 Day Psychedelic Pharmacology Podcast - Day 28 Legal and Regulatory Landscape
30 Day Psychedelic Pharmacology Podcast - Day 27 Cross-Species Comparisons
30 Day Psychedelic Pharmacology Podcast - Day 26 Long-Term Effects
30 Day Psychedelic Pharmacology Podcast - Day 25 Psychedelics in Oncology
30 Day Psychedelic Pharmacology Podcast - Day 24 Neuroinflammation and Immunity
30 Day Psychedelic Pharmacology Podcast - Day 23 Safety and Toxicology
30 Day Psychedelic Pharmacology Podcast - Day 22 Non-Hallucinogenic Serotonin Agonists
30 Day Psychedelic Pharmacology Podcast - Day 21 Gut Microbiome Interactions
30 Day Psychedelic Pharmacology Podcast - Day 20 Therapy Integration
30 Day Psychedelic Pharmacology Podcast - Day 19 Novel Formulations
30 Day Psychedelic Pharmacology Podcast - Day 18 Controversies in Psychedelic Science
30 Day Psychedelic Pharmacology Podcast - Day 17 Blinding, Functional Unblinding, and Placebo Challenges
30 Day Psychedelic Pharmacology Podcast - Day 16 Off-Receptor Targets and the Introduction of Ketamine
30 Day Psychedelic Pharmacology Podcast - Day 15 Set and Setting
30 Day Psychedelic Pharmacology Podcast - Day 14 Microdosing
30 Day Psychedelic Pharmacology Podcast - Day 13 Addiction
30 Day Psychedelic Pharmacology Podcast - Day 12 PTSD
30 Day Psychedelic Pharmacology Podcast - Day 11 Therapeutic Use for Depression
30 Day Psychedelic Pharmacology Podcast - Day 10 The Default Mode Network
30 Day Psychedelic Pharmacology Podcast - Day 9 Neuroplasticity
30 Day Psychedelic Pharmacology Podcast - Day 8 Mechanisms of Action
30 Day Psychedelic Pharmacology Podcast - Day 7 Ibogaine
30 Day Psychedelic Pharmacology Podcast - Day 6 MDMA
30 Day Psychedelic Pharmacology Podcast - Day 5 5-MeO-DMT
30 Day Psychedelic Pharmacology Podcast - Day 4 DMT
30 Day Psychedelic Pharmacology Podcast - Day 3 Psilocybin and Psilocin
30 Day Psychedelic Pharmacology Podcast - Day 2 LSD
30 Day Psychedelic Pharmacology Podcast - Day 1 History and Cultural Context
30 Day Psychedelic Pharmacology Podcast - Day 0 Introduction
Special Topics 30 Day Cannabinoid Pharmacology Podcast - Cannabinoid Hyperemesis Syndrome
Special Topics 30 Day Cannabinoid Pharmacology Podcast - Neuronal activity
Special Topics 30 Day Cannabinoid Pharmacology Podcast - hERG Channels
Special Topics 30 Day Cannabinoid Pharmacology Podcast - Synthetic Cannabinoids
Special Topics 30 Day Cannabinoid Pharmacology Podcast - CBD and Neuroplasticity v2
Special Topics 30 Day Cannabinoid Pharmacology Podcast - CBD and Neuroplasticity v1
Special Topics 30 Day Cannabinoid Pharmacology Podcast - PPAR
Special Topics 30 Day Cannabinoid Pharmacology Podcast - Membrane Bound Components
Special Topics 30 Day Cannabinoid Pharmacology Podcast - BDNF
Special Topics 30 Day Cannabinoid Pharmacology Podcast - eCB Production
Special Topics 30 Day Cannabinoid Pharmacology Podcast - p38 Pathway
Special Topics 30 Day Cannabinoid Pharmacology Podcast - JNK Pathway
Special Topics 30 Day Cannabinoid Pharmacology Podcast - ERK Pathway
Special Topics 30 Day Cannabinoid Pharmacology Podcast - Ca+2 and K+ channels
Special Topics 30 Day Cannabinoid Pharmacology Podcast - PKA_PKC Specificity
Special Topics 30 Day Cannabinoid Pharmacology Podcast - Cannabinoid SAR
Special Topics 30 Day Cannabinoid Pharmacology Podcast - PKA and PKC
Special Topics 30 Day Cannabinoid Pharmacology Podcast - G_alpha Subunits
30 Day Cannabinoid Pharmacology Podcast - Expert Level Cannabinoid Quiz Podcast
30 Day Cannabinoid Pharmacology Podcast - Non-Expert Cannabis Quiz Show Podcast
30 Day Cannabinoid Pharmacology Podcast - Day 30 Closing the Loop: The Future of Cannabinoid Science (not included in quizzes)
30 Day Cannabinoid Pharmacology Podcast - Day 29 Cannabinoid Research Gaps (not included in quizzes)
30 Day Cannabinoid Pharmacology Podcast - Day 28 Personalized Medicine and Cannabinoids
30 Day Cannabinoid Pharmacology Podcast - Day 27 Challenges in Cannabinoid Drug Development
30 Day Cannabinoid Pharmacology Podcast - Day 26 Cannabinoids and Aging
30 Day Cannabinoid Pharmacology Podcast - Day 25 Cannabinoids and Sexual Health
30 Day Cannabinoid Pharmacology Podcast - Day 24 Cannabinoids in Dermatology
30 Day Cannabinoid Pharmacology Podcast - Day 23 Cannabinoids in Epilepsy
30 Day Cannabinoid Pharmacology Podcast - Day 22 Cannabinoid Tolerance and Dependence
30 Day Cannabinoid Pharmacology Podcast - Day 21 Cannabinoid Metabolizing Enzymes
30 Day Cannabinoid Pharmacology Podcast - Day 20 Cannabinoids in Gastrointestinal Disorders
30 Day Cannabinoid Pharmacology Podcast - Day 19 ECS and Cardiovascular Health
30 Day Cannabinoid Pharmacology Podcast - Day 18 Cannabinoid Synergy The Entourage Effect
30 Day Cannabinoid Pharmacology Podcast - Day 17 Pharmacodynamics of Cannabinoids
30 Day Cannabinoid Pharmacology Podcast - Day 16 Pharmacokinetics of Cannabinoids
30 Day Cannabinoid Pharmacology Podcast - Day 15 Cannabinoids and Psychiatric Disorders
30 Day Cannabinoid Pharmacology Podcast - Day 14 ECS and Metabolic Regulation
30 Day Cannabinoid Pharmacology Podcast - Day 13 Cannabinoids and Cancer Pathways
30 Day Cannabinoid Pharmacology Podcast - Day 12 Cannabinoids in Inflammation
30 Day Cannabinoid Pharmacology Podcast - Day 11 ECS and Pain Modulation
30 Day Cannabinoid Pharmacology Podcast - Day 10 ECS and Neuroprotection
30 Day Cannabinoid Pharmacology Podcast - Day 9 Endocannabinoid System (ECS) in Homeostasis
30 Day Cannabinoid Pharmacology Podcast - Day 8 Cannabinoid Receptor Signal Transduction
30 Day Cannabinoid Pharmacology Podcast - Day 7 GPR55 and Other Atypical Cannabinoid Receptors
30 Day Cannabinoid Pharmacology Podcast - Day 6 TRP Channels and Cannabinoids
30 Day Cannabinoid Pharmacology Podcast - Day 5 Synthetic Cannabinoids Mechanisms and Applications
30 Day Cannabinoid Pharmacology Podcast - Day 4 Endocannabinoids Anandamide and 2-AG
30 Day Cannabinoid Pharmacology Podcast - Day 3 CB2 Receptor Structure and Function
30 Day Cannabinoid Pharmacology Podcast - Day 2 CB1 Receptor Structure and Distribution
30 Day Cannabinoid Pharmacology Podcast - Day 1 Introduction to Cannabinoid Pharmacology
30 Day Cannabinoid Pharmacology Podcast - Day 0 Cannabinoid Pharmacology Podcast Introduction and Instructions
30 Day FDA and ICH Drug Development Regulations - Expert-Quiz Podcast
30 Day FDA and ICH Drug Development Regulations - Non-Expert Quiz Podcast
30 Day FDA and ICH Drug Development Regulations - Day 30 Podcast Series Wrap-Up
30 Day FDA and ICH Drug Development Regulations - Day 30 Future Trends in Drug Development
30 Day FDA and ICH Drug Development Regulations - Day 29 Ethical Considerations
30 Day FDA and ICH Drug Development Regulations - Day 28 Global Drug Development Strategy
30 Day FDA and ICH Drug Development Regulations - Day 27 Regulatory Submissions
30 Day FDA and ICH Drug Development Regulations - Day 26 Validation of Computerized Systems (21 CFR Part 11)
30 Day FDA and ICH Drug Development Regulations - Day 25 ICH Quality Guidelines (Q10/Q11)
30 Day FDA and ICH Drug Development Regulations - Day 24 Accelerated Approval Pathways
30 Day FDA and ICH Drug Development Regulations - Day 23 Real-World Evidence (RWE)
30 Day FDA and ICH Drug Development Regulations - Day 22 Post-Marketing Surveillance
30 Day FDA and ICH Drug Development Regulations - Day 21 Biologics and Biosimilars
30 Day FDA and ICH Drug Development Regulations - Day 20 ICH Efficacy Guidelines
30 Day FDA and ICH Drug Development Regulations - Day 19 Nutraceuticals vs. Prescription Drugs
30 Day FDA and ICH Drug Development Regulations - Day 18 GRAS (Generally Recognized as Safe)
30 Day FDA and ICH Drug Development Regulations - Day 17 Over-the-Counter (OTC) vs. Prescription Drugs
30 Day FDA and ICH Drug Development Regulations - Day 16 Safety Pharmacology (ICH S7)
30 Day FDA and ICH Drug Development Regulations - Day 15 Controlled Substances
30 Day FDA and ICH Drug Development Regulations - Day 14 Current Good Manufacturing Practices (cGMPs)
30 Day FDA and ICH Drug Development Regulations - Day 13 Mutagenic Impurities (ICH M7)
30 Day FDA and ICH Drug Development Regulations - Day 12 Control of Impurities (ICH Q3A-Q3E)
30 Day FDA and ICH Drug Development Regulations - Day 11 Analytical Validation (ICH Q2)
30 Day FDA and ICH Drug Development Regulations - Day 10 Quality by Design (QbD)
30 Day FDA and ICH Drug Development Regulations - Day 9 Drug Product Development
30 Day FDA and ICH Drug Development Regulations - Day 8 Drug Substance Production (ICH Q7)
30 Day FDA and ICH Drug Development Regulations - Day 7 Common Technical Document (CTD)
30 Day FDA and ICH Drug Development Regulations - Day 6 Good Clinical Practice (ICH E6)
30 Day FDA and ICH Drug Development Regulations - Day 5 Clinical Trials - Phases and Requirements
30 Day FDA and ICH Drug Development Regulations - Day 4 ICH Safety Guidelines
30 Day FDA and ICH Drug Development Regulations - Day 3 Pre-Clinical Development
30 Day FDA and ICH Drug Development Regulations - Day 2 FDA Overview
30 Day FDA and ICH Drug Development Regulations - Day 1 ICH Overview
30 Day FDA and ICH Drug Development Regulations - Day 0 Introduction
Series Introduction - Structure, Format, and Learning Outcomes